Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration

Published:2023-12-06 Issue: Volume: Page:1-11
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Yu Yimin¹^ORCID,He Jingjing²,Huang Zhiwei¹^ORCID,Li Yan¹,Wu Ying¹,Shen Yifeng¹,Zhou Yanling²,Bao Cungang²,Jin Zhiping²,Li Huafang¹³⁴^ORCID

Affiliation:

1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2. Shanghai Research Institute, Zhejiang Jingxin Pharmaceutical Co.,Ltd, Shanghai, China

3. Shanghai Clinical Research Center for Mental Health, Shanghai, China

4. Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China

Funder

Shanghai Clinical Research Center for Mental Health

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2291470

Reference40 articles.

1. Schizophrenia

2. The Epidemiology and Global Burden of Schizophrenia

3. Schizophrenia

4. Attenuated psychosis syndrome in DSM-5

5. Global estimates of service coverage for severe mental disorders: findings from the WHO Mental Health Atlas 2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP